Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / CL A
-
Number of holders
-
57
-
Total 13F shares, excl. options
-
4,066,874
-
Shares change
-
-2,105,914
-
Total reported value, excl. options
-
$128,667,792
-
Value change
-
-$65,567,868
-
Number of buys
-
38
-
Number of sells
-
-14
-
Price
-
$31.64
Significant Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q2 2017
62 filings reported holding RETA - REATA PHARMACEUTICALS INC - CL A as of Q2 2017.
REATA PHARMACEUTICALS INC - CL A (RETA) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,066,874 shares
.
Largest 10 shareholders include Novo Holdings A/S (592,794 shares), BlackRock Inc. (458,483 shares), FMR LLC (414,491 shares), EMERALD ADVISERS INC/PA (406,426 shares), VANGUARD GROUP INC (295,540 shares), EMERALD MUTUAL FUND ADVISERS TRUST (293,927 shares), PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE (250,000 shares), JPMORGAN CHASE & CO (232,562 shares), STATE STREET CORP (108,212 shares), and NORTHERN TRUST CORP (98,046 shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.